Pfizer Joins Russia Land Rush, But Chooses To Partner Rather Than Build

Pfizer Inc. has signed a memorandum of understanding with ChemRar High Tech Center, a Moscow incubator, to explore a collaboration focused on research, development and commercialization of innovative drugs in Russia and other countries.